FloBio is pioneering a novel point-of-care (POC) diagnostic platform that assesses blood clotting status under physiologic and dynamic flow. Our proprietary microfluidic technology is designed to set a new standard for monitoring blood function in emergency, critical care settings. Rapid and real-time measurements precisely identify the clotting defects, enabling clinicians to personalize management of bleeding and thrombotic risk within the critical decision making window. The result is fewer patient complications, improved clinical outcomes, and reduced healthcare costs.